Which goal is associated with the use of montelukast for asthma symptoms?

Montelukast is a leukotriene receptor antagonist that is primarily used to manage asthma symptoms. The main goal of using montelukast in asthma management is to reduce airway inflammation, bronchoconstriction, and subsequently lessening the frequency and severity of asthma symptoms. By blocking the effects of leukotrienes, which are inflammatory mediators involved in allergic responses and asthma pathophysiology, montelukast helps to maintain better control over asthma. This leads to fewer exacerbations, improved lung function, and overall enhanced quality of life for patients with asthma.